Free Trial

ORIX (ORXCF) Financials

ORIX logo
$25.66 0.00 (0.00%)
As of 08/7/2025
Annual Income Statements for ORIX

Annual Income Statements for ORIX

This table shows ORIX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders
2,946 2,908 2,825 1,739 2,613 2,187 2,289 2,346
Consolidated Net Income / (Loss)
3,026 2,937 2,862 1,779 2,659 2,237 2,239 2,346
Net Income / (Loss) Continuing Operations
3,026 2,937 2,862 1,779 2,659 2,237 2,239 2,346
Total Pre-Tax Income
4,097 3,554 3,850 2,600 4,195 2,954 3,108 3,205
Total Operating Income
3,163 2,959 2,517 2,340 2,412 2,530 2,385 2,214
Total Gross Profit
7,454 7,132 7,318 20,581 20,608 20,004 18,472 19,053
Total Revenue
26,935 21,867 21,279 20,726 20,653 20,065 18,611 19,178
Operating Revenue
- - - 20,726 20,653 20,065 18,611 19,178
Total Cost of Revenue
19,481 14,736 13,961 145 44 61 139 125
Other Cost of Revenue
- - - 145 44 61 139 125
Total Operating Expenses
4,291 4,173 4,802 18,241 18,196 17,474 16,087 16,840
Selling, General & Admin Expense
4,061 3,925 4,294 4,129 4,305 4,214 4,150 4,310
Other Operating Expenses / (Income)
166 214 367 14,031 13,598 13,242 11,925 12,357
Impairment Charge
64 34 140 81 294 17 11 173
Total Other Income / (Expense), net
934 595 1,333 260 1,783 424 723 992
Interest & Investment Income
471 296 634 4.35 202 166 243 381
Other Income / (Expense), net
463 299 699 256 1,581 257 479 610
Income Tax Expense
1,072 617 988 820 1,537 717 869 859
Net Income / (Loss) Attributable to Noncontrolling Interest
80 30 38 40 45 50 -50 0.03
Weighted Average Basic Shares Outstanding
- 1.32B 1.32B 1.29B 1.26B 1.23B 1.21B 1.16B
Weighted Average Diluted Shares Outstanding
- 1.32B 1.32B 1.29B 1.26B 1.23B 1.21B 1.16B
Weighted Average Basic & Diluted Shares Outstanding
- 1.32B 1.32B 1.29B 1.26B 1.23B 1.21B 1.16B
Cash Dividends to Common per Share
$0.53 $69.00 $81.00 $76.00 $0.68 $0.67 $0.57 $0.79

Quarterly Income Statements for ORIX

No quarterly income statements for ORIX are available.


Annual Cash Flow Statements for ORIX

This table details how cash moves in and out of ORIX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Net Change in Cash & Equivalents
2,558 -1,092 -1,384 -504 101 2,072 -1,201 912
Net Cash From Operating Activities
5,352 5,278 9,728 9,966 9,086 6,878 8,222 8,674
Net Cash From Continuing Operating Activities
5,352 5,278 9,728 9,966 9,086 6,878 8,222 8,674
Net Income / (Loss) Continuing Operations
3,026 2,937 2,862 1,779 2,659 2,237 2,239 2,346
Consolidated Net Income / (Loss)
3,026 2,937 2,862 1,779 2,659 2,237 2,239 2,346
Depreciation Expense
2,634 2,655 2,839 2,856 2,638 2,563 2,409 2,665
Non-Cash Adjustments To Reconcile Net Income
-653 -1,386 2,760 3,243 1,071 1,980 1,930 1,698
Changes in Operating Assets and Liabilities, net
345 1,072 1,267 2,087 2,718 98 1,645 1,964
Net Cash From Investing Activities
-4,131 -7,849 -13,722 -10,938 -6,660 -8,275 -9,078 -8,737
Net Cash From Continuing Investing Activities
-4,131 -7,849 -13,722 -10,938 -6,660 -8,275 -9,078 -8,737
Purchase of Property, Plant & Equipment
-9,891 -9,522 -9,265 -6,877 -7,553 -8,136 -7,941 -9,057
Acquisitions
-621 -1,070 -1,259 -743 -721 -2,057 -1,383 -1,033
Purchase of Investments
-5,174 -8,094 -7,556 -7,942 -5,337 -4,304 -4,153 -5,185
Sale of Property, Plant & Equipment
2,690 3,855 3,168 1,256 1,211 1,759 1,737 2,494
Divestitures
1,110 1,015 1,603 899 2,533 937 1,081 1,380
Sale and/or Maturity of Investments
5,624 3,397 3,418 3,148 3,250 3,049 1,982 3,857
Other Investing Activities, net
2,129 2,569 -3,831 -679 -43 478 -401 -1,192
Net Cash From Financing Activities
1,327 1,497 2,694 361 -2,525 3,302 -565 996
Net Cash From Continuing Financing Activities
1,327 1,497 2,694 361 -2,525 3,302 -565 996
Repayment of Debt
-12,741 -8,932 -7,654 -9,662 -9,697 -8,708 -7,726 -9,796
Repurchase of Common Equity
-368 -6.35 -427 -501 -412 -392 -331 -357
Payment of Dividends
-791 -1,568 -1,011 -904 -836 -1,150 -661 -908
Issuance of Debt
14,002 10,094 8,630 10,589 8,618 13,715 8,060 10,339
Issuance of Common Equity
45 204 224 221 214 30 103 24
Other Financing Activities, net
1,179 1,705 2,932 617 -412 -193 -10 1,695
Effect of Exchange Rate Changes
12 -17 -84 108 200 167 220 -21

Quarterly Cash Flow Statements for ORIX

No quarterly cash flow statements for ORIX are available.


Annual Balance Sheets for ORIX

This table presents ORIX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Total Assets
109,343 121,940 122,609 117,512 115,174 107,936 112,517
Total Current Assets
58,628 75,007 73,357 69,295 69,427 60,752 34,668
Cash & Equivalents
10,427 9,170 8,599 7,863 9,280 6,830 8,049
Restricted Cash
1,101 1,424 1,160 1,128 1,017 1,008 770
Short-Term Investments
29,437 34,904 33,183 31,807 29,416 26,179 21,578
Accounts Receivable
2,520 2,918 3,203 2,964 3,328 2,654 2,742
Inventories, net
1,039 1,176 1,285 1,149 1,273 1,503 1,529
Plant, Property, & Equipment, net
15,964 5,249 4,446 4,627 4,678 4,560 0.00
Total Noncurrent Assets
34,750 41,684 32,075 31,541 21,487 21,578 78,370
Long-Term Investments
24,892 28,620 32,075 31,541 21,487 21,578 21,929
Noncurrent Note & Lease Receivables
9,858 13,064 - - - - 7,831
Other Noncurrent Operating Assets
- - - - - - 48,610
Total Liabilities & Shareholders' Equity
109,343 121,940 122,609 117,512 115,174 107,936 112,517
Total Liabilities
82,732 93,235 94,557 89,750 87,941 81,322 84,663
Total Current Liabilities
23,106 26,870 26,287 25,713 23,708 21,478 22,280
Short-Term Debt
2,780 3,143 2,778 3,620 3,833 3,796 3,667
Accounts Payable
2,636 2,638 2,357 2,400 2,763 2,397 2,270
Customer Deposits
17,313 20,825 20,952 18,743 16,922 14,851 16,343
Total Noncurrent Liabilities
59,626 66,365 68,269 64,037 64,233 59,843 62,387
Long-Term Debt
37,596 39,933 39,928 36,455 39,245 37,207 38,246
Noncurrent Deferred & Payable Income Tax Liabilities
2,819 3,062 3,085 2,848 3,232 3,341 3,507
Other Noncurrent Operating Liabilities
19,211 23,370 25,256 24,735 21,756 19,296 20,634
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
88 96 - 0.00 7.12 17 23
Total Equity & Noncontrolling Interests
26,523 28,609 28,052 27,762 27,227 26,597 27,830
Total Preferred & Common Equity
26,019 27,935 27,377 26,856 26,694 26,064 27,283
Total Common Equity
26,019 27,935 27,377 26,856 26,694 26,064 27,283
Common Stock
4,300 4,467 4,343 3,966 3,422 3,006 3,037
Retained Earnings
22,952 25,703 24,811 23,957 23,009 21,556 22,381
Treasury Stock
-682 -1,130 -1,012 -934 -913 -860 -412
Accumulated Other Comprehensive Income / (Loss)
-551 -1,106 -765 -132 1,176 2,362 2,277
Noncontrolling Interest
504 674 675 906 533 532 547

Quarterly Balance Sheets for ORIX

No quarterly balance sheets for ORIX are available.


Annual Metrics And Ratios for ORIX

This table displays calculated financial ratios and metrics derived from ORIX's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 3/31/2015 3/31/2016 3/31/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
36.83% 16.89% 13.31% 0.00% -18.81% -2.69% -2.60% -0.35% -2.84% -7.25% 3.05%
EBITDA Growth
-0.97% 16.63% 10.69% 6.92% -5.55% 2.40% -9.96% 21.63% -19.30% -1.45% 4.09%
EBIT Growth
1.25% 18.26% 15.54% 1.37% -10.15% -1.29% -19.30% 53.85% -30.18% 2.75% -1.43%
NOPAT Growth
23.72% 12.30% 9.46% 19.54% 4.68% -23.48% -14.41% -4.55% 25.36% -10.31% -5.73%
Net Income Growth
13.13% 13.88% 3.90% 0.00% -2.93% -2.55% -37.84% 49.43% -15.86% 0.10% 4.77%
EPS Growth
25.15% 10.78% 5.12% 0.00% 3.50% -6.15% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth
-53.35% 112.60% 14.60% 0.00% -1.38% 84.31% 2.45% -8.83% -24.30% 19.54% 5.49%
Free Cash Flow Firm Growth
1,293.70% -106.69% 461.83% 34.47% -73.52% 1,072.92% -4.30% -95.70% -824.38% 96.18% -18,460.58%
Invested Capital Growth
-89.73% 179.45% -39.80% 0.00% 0.00% -1,199.40% -105.93% 3.49% 26.40% 10.42% 210.32%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
37.94% 33.66% 31.07% 27.67% 32.61% 34.39% 99.30% 99.79% 99.70% 99.26% 99.35%
EBITDA Margin
24.98% 24.92% 24.35% 23.24% 27.04% 28.45% 26.30% 32.11% 26.67% 28.33% 28.62%
Operating Margin
11.81% 12.15% 12.29% 11.74% 13.53% 11.83% 11.29% 11.68% 12.61% 12.82% 11.54%
EBIT Margin
14.42% 14.59% 14.87% 13.46% 14.90% 15.11% 12.52% 19.33% 13.89% 15.39% 14.72%
Profit (Net Income) Margin
11.74% 11.44% 10.49% 11.23% 13.43% 13.45% 8.58% 12.87% 11.15% 12.03% 12.23%
Tax Burden Percent
74.20% 69.25% 66.11% 73.84% 82.64% 74.35% 68.44% 63.37% 75.71% 72.04% 73.19%
Interest Burden Percent
109.74% 113.22% 106.66% 113.00% 109.09% 119.71% 100.17% 105.07% 105.97% 108.49% 113.51%
Effective Tax Rate
25.89% 30.75% 33.89% 26.16% 17.36% 25.65% 31.56% 36.63% 24.29% 27.96% 26.81%
Return on Invested Capital (ROIC)
18.93% 60.18% 55.83% 0.00% 432.75% 0.00% 0.00% 0.00% 0.00% 0.00% 192.81%
ROIC Less NNEP Spread (ROIC-NNEP)
14.39% 56.63% 52.92% 0.00% 428.88% 0.00% 0.00% 0.00% 0.00% 0.00% 190.06%
Return on Net Nonoperating Assets (RNNOA)
-8.45% -48.66% -44.88% 0.00% -410.67% 0.00% 0.00% 0.00% 0.00% 0.00% -184.20%
Return on Equity (ROE)
10.49% 11.52% 10.95% 0.00% 22.08% 10.35% 6.27% 9.53% 8.13% 8.32% 8.61%
Cash Return on Invested Capital (CROIC)
181.69% -34.41% 105.52% 0.00% 232.75% 0.00% 0.00% 0.00% 0.00% 0.00% -181.62%
Operating Return on Assets (OROA)
2.86% 3.19% 3.59% 0.00% 2.98% 2.78% 2.12% 3.33% 2.40% 2.57% 2.56%
Return on Assets (ROA)
2.33% 2.50% 2.53% 0.00% 2.69% 2.48% 1.46% 2.21% 1.92% 2.01% 2.13%
Return on Common Equity (ROCE)
9.41% 10.58% 10.28% 0.00% 21.58% 10.09% 6.11% 9.26% 7.92% 8.15% 8.44%
Return on Equity Simple (ROE_SIMPLE)
11.86% 11.73% 11.20% 0.00% 11.29% 10.25% 6.50% 9.90% 8.38% 8.59% 8.60%
Net Operating Profit after Tax (NOPAT)
1,590 1,785 1,954 2,336 2,445 1,871 1,601 1,528 1,916 1,718 1,620
NOPAT Margin
8.75% 8.41% 8.12% 8.67% 11.18% 8.79% 7.73% 7.40% 9.55% 9.23% 8.45%
Net Nonoperating Expense Percent (NNEP)
4.54% 3.55% 2.91% 0.00% 3.86% 2.98% 0.38% 2.13% 0.66% 1.18% 2.75%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - - 2.32%
Cost of Revenue to Revenue
62.06% 66.34% 68.93% 72.33% 67.39% 65.61% 0.70% 0.21% 0.30% 0.75% 0.65%
SG&A Expenses to Revenue
19.68% 17.84% 15.63% 15.08% 17.95% 20.18% 19.92% 20.84% 21.00% 22.30% 22.47%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
26.12% 21.52% 18.78% 15.93% 19.08% 22.57% 88.01% 88.11% 87.08% 86.44% 87.81%
Earnings before Interest and Taxes (EBIT)
2,618 3,096 3,577 3,626 3,258 3,216 2,595 3,993 2,788 2,865 2,824
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
4,535 5,289 5,855 6,260 5,913 6,055 5,451 6,631 5,351 5,273 5,489
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.84 0.76 0.75 0.00 0.00 0.00 0.82 0.96 0.77 1.04 0.93
Price to Tangible Book Value (P/TBV)
0.84 0.76 0.75 0.00 0.00 0.00 0.82 0.96 0.77 1.04 0.93
Price to Revenue (P/Rev)
0.83 0.74 0.70 0.00 0.00 0.00 1.08 1.24 1.03 1.46 1.32
Price to Earnings (P/E)
7.68 6.75 6.89 0.00 0.00 0.00 12.92 9.82 9.44 11.89 10.82
Dividend Yield
0.00% 3.31% 3.67% 3.72% 5.15% 6.09% 2.32% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
13.03% 14.80% 14.51% 0.00% 0.00% 0.00% 7.74% 10.18% 10.59% 8.41% 9.24%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.87
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.15 0.71 0.81
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.57 2.50 2.83
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.10 4.60 5.50
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.60 7.67 9.59
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.45 1.60 1.79
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.85 1.73 1.56 0.00 1.52 1.50 1.52 1.44 1.58 1.54 1.50
Long-Term Debt to Equity
1.73 1.59 1.45 0.00 1.41 1.39 1.42 1.31 1.44 1.40 1.37
Financial Leverage
-0.59 -0.86 -0.85 0.00 -0.96 -1.20 -1.67 -1.90 -1.78 -1.64 -0.97
Leverage Ratio
4.50 4.61 4.33 0.00 4.11 4.18 4.31 4.30 4.23 4.14 4.05
Compound Leverage Factor
4.94 5.21 4.62 0.00 4.48 5.01 4.32 4.52 4.48 4.50 4.59
Debt to Total Capital
64.94% 63.35% 60.93% 0.00% 60.28% 60.01% 60.35% 59.08% 61.27% 60.64% 60.08%
Short-Term Debt to Total Capital
4.19% 5.17% 4.17% 0.00% 4.15% 4.38% 3.93% 5.34% 5.45% 5.61% 5.26%
Long-Term Debt to Total Capital
60.75% 58.18% 56.75% 0.00% 56.13% 55.63% 56.43% 53.74% 55.82% 55.03% 54.82%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
3.42% 2.51% 2.16% 0.00% 0.88% 1.07% 0.95% 1.34% 0.77% 0.81% 0.82%
Common Equity to Total Capital
31.64% 34.14% 36.92% 0.00% 38.84% 38.92% 38.69% 39.59% 37.97% 38.55% 39.11%
Debt to EBITDA
8.13 7.26 6.35 0.00 6.83 7.11 7.83 6.04 8.05 7.78 7.64
Net Debt to EBITDA
-4.05 -3.37 -3.62 0.00 -4.31 -5.13 -5.93 -4.87 -3.39 -2.77 -1.90
Long-Term Debt to EBITDA
7.61 6.67 5.91 0.00 6.36 6.60 7.32 5.50 7.33 7.06 6.97
Debt to NOPAT
23.21 21.51 19.02 0.00 16.51 23.02 26.67 26.22 22.48 23.86 25.87
Net Debt to NOPAT
-11.55 -10.00 -10.85 0.00 -10.42 -16.59 -20.18 -21.11 -9.46 -8.49 -6.43
Long-Term Debt to NOPAT
21.71 19.76 17.71 0.00 15.38 21.34 24.93 23.85 20.48 21.65 23.61
Altman Z-Score
1.28 1.01 1.35 0.00 0.00 0.00 1.13 1.19 1.15 1.18 0.84
Noncontrolling Interest Sharing Ratio
10.24% 8.22% 6.16% 0.00% 2.22% 2.46% 2.55% 2.83% 2.63% 2.02% 2.06%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.37 2.49 3.50 0.00 2.54 2.79 2.79 2.70 2.93 2.83 1.56
Quick Ratio
3.41 1.66 2.75 0.00 1.83 1.73 1.71 1.66 1.77 1.66 1.45
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
15,252 -1,021 3,693 4,966 1,315 15,425 14,761 635 -4,603 -176 -32,616
Operating Cash Flow to CapEx
35.94% 60.58% 87.32% 74.32% 93.13% 159.54% 177.30% 143.26% 107.85% 132.54% 132.15%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.20 0.22 0.24 0.00 0.20 0.18 0.17 0.17 0.17 0.17 0.17
Accounts Receivable Turnover
7.60 7.65 9.28 0.00 8.68 7.83 6.77 6.70 6.38 6.22 7.11
Inventory Turnover
9.37 10.68 14.34 0.00 14.18 12.61 0.12 0.04 0.05 0.10 0.08
Fixed Asset Turnover
7.01 8.08 7.39 0.00 1.37 2.01 4.28 4.55 4.31 4.03 0.00
Accounts Payable Turnover
4.21 5.43 7.14 0.00 5.59 5.29 0.06 0.02 0.02 0.05 0.05
Days Sales Outstanding (DSO)
48.00 47.71 39.34 0.00 42.06 46.64 53.90 54.50 57.23 58.66 51.35
Days Inventory Outstanding (DIO)
38.96 34.17 25.45 0.00 25.74 28.95 3,101.11 10,013.19 7,230.34 3,654.67 4,431.19
Days Payable Outstanding (DPO)
86.66 67.27 51.14 0.00 65.29 68.94 6,294.39 19,565.31 15,410.62 6,792.37 6,819.76
Cash Conversion Cycle (CCC)
0.30 14.61 13.65 0.00 2.51 6.65 -3,139.38 -9,497.63 -8,123.05 -3,079.03 -2,337.23
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,563 4,369 2,630 0.00 1,130 -12,424 -25,584 -24,691 -18,172 -16,278 17,958
Invested Capital Turnover
2.16 7.15 6.87 0.00 38.70 -3.77 -1.09 -0.82 -0.94 -1.08 22.82
Increase / (Decrease) in Invested Capital
-13,663 2,806 -1,739 -2,630 1,130 -13,554 -13,160 893 6,519 1,894 34,236
Enterprise Value (EV)
-1,347 -585 -2,974 0.00 0.00 0.00 -9,174 -5,682 3,073 13,173 15,537
Market Capitalization
15,062 15,742 16,910 0.00 0.00 0.00 22,463 25,676 20,656 27,216 25,381
Book Value per Share
$13.59 $15.64 $17.00 $0.00 $19.64 $21.09 $20.67 $20.89 $21.21 $21.11 $22.46
Tangible Book Value per Share
$13.59 $15.64 $17.00 $0.00 $19.64 $21.09 $20.67 $20.89 $21.21 $21.11 $22.46
Total Capital
56,808 60,617 60,983 0.00 66,987 71,781 70,757 67,837 70,311 67,617 69,767
Total Debt
36,891 38,399 37,154 0.00 40,376 43,076 42,705 40,075 43,077 41,003 41,913
Total Long-Term Debt
34,513 35,267 34,609 0.00 37,596 39,933 39,928 36,455 39,245 37,207 38,246
Net Debt
-18,353 -17,849 -21,199 0.00 -25,480 -31,042 -32,313 -32,264 -18,123 -14,593 -10,413
Capital Expenditures (CapEx)
5,985 7,549 6,002 7,200 5,667 6,097 5,621 6,342 6,378 6,204 6,563
Debt-free, Cash-free Net Working Capital (DFCFNWC)
4,062 2,020 -763 0.00 -2,662 5,782 6,905 6,406 9,839 9,053 -14,342
Debt-free Net Working Capital (DFNWC)
56,148 30,293 52,884 0.00 38,302 51,281 49,847 47,203 49,552 43,070 16,055
Net Working Capital (NWC)
53,770 27,161 50,339 0.00 35,522 48,138 47,070 43,583 45,719 39,274 12,388
Net Nonoperating Expense (NNE)
-542 -642 -568 -690 -492 -991 -178 -1,130 -321 -521 -726
Net Nonoperating Obligations (NNO)
-18,353 -17,849 -21,199 0.00 -25,480 -41,129 -53,636 -52,452 -45,405 -42,892 -9,895
Total Depreciation and Amortization (D&A)
1,917 2,193 2,277 2,634 2,655 2,839 2,856 2,638 2,563 2,409 2,665
Debt-free, Cash-free Net Working Capital to Revenue
22.37% 9.52% -3.17% 0.00% -12.18% 27.17% 33.31% 31.02% 49.03% 48.64% -74.78%
Debt-free Net Working Capital to Revenue
309.24% 142.73% 219.90% 0.00% 175.16% 240.99% 240.51% 228.56% 246.95% 231.42% 83.71%
Net Working Capital to Revenue
296.14% 127.98% 209.32% 0.00% 162.44% 226.22% 227.11% 211.03% 227.85% 211.03% 64.59%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$179.47 $0.00 $0.00 $0.00 $0.00 $237.38 $155.54 $259.37 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
1.32B 0.00 0.00 0.00 0.00 1.32B 1.29B 1.26B 1.23B 1.21B 1.16B
Adjusted Diluted Earnings per Share
$179.21 $0.00 $0.00 $0.00 $0.00 $237.17 $155.39 $259.07 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
1.32B 0.00 0.00 0.00 0.00 1.32B 1.29B 1.26B 1.23B 1.21B 1.16B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.32B 0.00 0.00 0.00 0.00 1.32B 1.29B 1.26B 1.23B 1.21B 1.16B
Normalized Net Operating Profit after Tax (NOPAT)
1,861 1,896 2,047 2,383 2,473 1,975 1,657 1,715 1,929 1,727 1,747
Normalized NOPAT Margin
10.25% 8.94% 8.51% 8.85% 11.31% 9.28% 7.99% 8.30% 9.61% 9.28% 9.11%
Pre Tax Income Margin
15.82% 16.52% 15.86% 15.21% 16.25% 18.09% 12.54% 20.31% 14.72% 16.70% 16.71%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
13.07% 33.98% 31.02% 26.14% 53.39% 35.32% 50.79% 31.43% 51.40% 29.54% 38.71%
Augmented Payout Ratio
13.07% 33.98% 35.34% 38.30% 53.61% 50.22% 78.96% 46.92% 68.93% 44.30% 53.93%

Quarterly Metrics And Ratios for ORIX

No quarterly metrics and ratios for ORIX are available.


Frequently Asked Questions About ORIX's Financials

When does ORIX's financial year end?

According to the most recent income statement we have on file, ORIX's fiscal year ends in March. Their fiscal year 2025 ended on March 31, 2025.

How has ORIX's net income changed over the last 7 years?

ORIX's net income appears to be on a downward trend, with a most recent value of $2.35 billion in 2025, falling from $3.03 billion in 2018. The previous period was $2.24 billion in 2024.

What is ORIX's operating income?
ORIX's total operating income in 2025 was $2.21 billion, based on the following breakdown:
  • Total Gross Profit: $19.05 billion
  • Total Operating Expenses: $16.84 billion
How has ORIX's revenue changed over the last 7 years?

Over the last 7 years, ORIX's total revenue changed from $26.93 billion in 2018 to $19.18 billion in 2025, a change of -28.8%.

How much debt does ORIX have?

ORIX's total liabilities were at $84.66 billion at the end of 2025, a 4.1% increase from 2024, and a 2.3% increase since 2019.

How much cash does ORIX have?

In the past 6 years, ORIX's cash and equivalents has ranged from $6.83 billion in 2024 to $10.43 billion in 2019, and is currently $8.05 billion as of their latest financial filing in 2025.

How has ORIX's book value per share changed over the last 10 years?

Over the last 10 years, ORIX's book value per share changed from 13.59 in 2015 to 22.46 in 2025, a change of 65.3%.



This page (OTCMKTS:ORXCF) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners